Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
12.91 USD | +0.16% | -1.97% | -9.78% |
05-14 | Transcript : OptimizeRx Corporation, Q1 2024 Earnings Call, May 14, 2024 | |
05-14 | OptimizeRx Corporation Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-9.78% | 235M | |
+30.93% | 456B | |
+32.17% | 280B | |
+6.33% | 134B | |
+29.89% | 94.31B | |
+5.36% | 91.48B | |
+58.92% | 60.48B | |
+13.95% | 46.13B | |
+25.91% | 37.31B | |
-0.26% | 35.48B |
- Stock Market
- Equities
- OPRX Stock
- News OptimizeRx Corporation
- B. Riley Cuts OptimizeRx's Price Target to $18 From $28 on Muted H2 Revenue Expectation, Keeps Buy Rating